Loading clinical trials...
Loading clinical trials...
Patients with Amyotrophic Lateral Sclerosis (ALS) typically endure a progressive paralysis due to the continued loss of motoneurons that leads them to death in less than 5 years. No treatment has chan...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
General Hospital of Chinese Armed Police Forces
NCT05204017 · Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis, and more
NCT07322003 · Amyotrophic Lateral Sclerosis
NCT07414212 · Amyotrophic Lateral Sclerosis
NCT07401121 · ALS (Amyotrophic Lateral Sclerosis)
NCT05104710 · Amyotrophic Lateral Sclerosis
Yihua An
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions